Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.90	42.21	41.83
Graham Fair Price	-4.70	4.21	4.42
PEG	221.15	-4.11	1.28
Price/Book	6.13	1.95	1.84
Price/Cash Flow	-30.46	246.28	354.17
Prices/Earnings	20.55	34.21	28.38
Price/Sales	2.02	20.85	20.44
Price/FCF	-30.46	246.28	354.17
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	6.04	0.36	0.34
Operating Margin	8.83	0.29	0.27
ROA	-11.21	0.01	0.01
ROE	0.02	0.01	-11.97
ROIC	0.02	0.02	-31.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-1.00	1.49	-32.76
Dividends QOQ	-0.01	0.01	-11.79
EBIT QOQ	-0.15	0.15	2.03
EPS QOQ	0.22	-0.08	-62.46
FCF QOQ	-0.60	0.55	-7.67
Revenue QOQ	0.02	0.06	165.18
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	139.99	127.77	-8.73
Days Sales Outstanding (DSO)	18.27	12.85	-29.68
Inventory Turnover	0.64	0.70	9.56
Debt/Capitalization	< 0.005	0.00	inf
Quick Ratio	1.17	1.45	23.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.33	7.44	1.57
Cash	0.60	0.65	8.34
Capex	-0.28	-0.21	24.87
Free Cash Flow	0.04	0.06	55.02
Revenue	0.66	0.70	5.66
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.36	2.79	18.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.82	-1.83	-0.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating